Hyperadrenalism in Childhood and Adolescence by THOMAS, COLIN et al.
Hyperadrenalism in Childhood and Adolescence
COLIN G. THOMAS, JR., M.D., ANN T. SMITH, M.D., JAY M. GRIFFITH, B.S., FREDERIC B. ASKIN, M.D.
Hyperadrenalism in childhood and adolescence has unique fea-
tures that influence diagnosis and management. We reviewed
our experience with 18 patients, ranging in age from 18 months
to 18 years. Nine had bilateral adrenal hyperplasia, eight had
adrenal neoplasms, and one had micronodular hyperplasia. Pa-
tients with congenital adrenal hyperplasia and hyperaldoste-
ronism were excluded. Six patients with Cushing's disease di-
agnosed in earlier years were treated by total adrenalectomy
and recently two patients underwent transsphenoidal removal
of pituitary tumors. Bilateral adrenalectomy was carried out in
one patient with micronodular hyperplasia and in a second be-
cause of elevated adrenocorticotrophic hormone (ACTH) levels
from an undefined source. Eight patients had adrenal neoplasms,
including five adenomas and three carcinomas. We found no
reliable criteria to differentiate before surgery between adrenal
adenomas and adrenal carcinomas. The most recognizable char-
acteristic of malignancy was tumor size, specifically weight
greater than 75 gms. Of the three patients with adrenal car-
cinoma, one expired 20 months after adrenalectomy and 8 months
after receiving palliative partial hepatectomy for liver metastasis.
Two patients are well with normal growth and development at
11 and 20 years following adrenalectomy. With the exception
of one patient who died 6 years after surgery from a glioblastoma
multiforme, all patients with adrenal adenomas are well. Eight
patients underwent bilateral adrenalectomy for hypercortisolism.
Five of the six who have reached their adult stature are sig-
nificantly stunted. Four of six patients with Cushing's disease,
treated by total adrenalectomy, have developed Nelson's syn-
drome at 2, 6, 10, and 12 years after surgery. Of the two patients
undergoing transsphenoidal surgery, one had recurrent disease
at 2 years and was treated by pituitary irradiation with recovery.
The patients undergoing adrenalectomy for micronodular hy-
perplasia and ectopic ACTH are well at 2 and 4 years, respec-
tively. Cushing's disease in children and adolescents is best
treated by transsphenoidal removal of the pituitary adenoma.
Adrenalectomy, once the most accepted approach, plays a sec-
ondary role and is indicated primarily in micronodular adrenal
hyperplasia, in patients with ectopic ACTH production of an
undefined source, and in recurrent Cushing's disease following
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prior pituitary irradiation. The high incidence of Nelson's syn-
drome in children treated by adrenalectomy mandates that pa-
tients at risk be monitored lifelong for the progression of a
pituitary tumor. Irradiation should be considered in patients
with recurrent Cushing's disease following transsphenoidal sur-
gery and as an alternative to hypophysectomy in the prepubertal
patient with Nelson's syndrome. Adrenalectomy remains the
treatment of choice for adrenal tumors with the prognosis being
excellent in neoplasms weighing less than 75 gms.
A DRENOCORTICAL HYPERFUNCTION in childhood and
) adolescence is an uncommon occurrence and has
unique features that influence diagnosis and management.
In children, hypercortisolism ofpituitary origin (Cushing's
disease) is manifest primarily by growth failure and other
physical features of cortisol excess, whereas adrenal neo-
plasms may produce cushingoid features, growth accel-
eration, masculinization, feminization, or a combination
of these features. Rarely is there an ectopic source of
ACTH in this age group. While adrenalectomy plays a
primary role in the treatment of adrenal neoplasms, the
ability to remove pituitary microadenomas by the trans-
sphenoidal approach has changed the indications for ad-
renalectomy in Cushing's disease. Children present a par-
ticular challenge in management because of the need to
assure normal growth and development.
This study reviews our experience over the past 2 de-
cades in the management of adrenocortical hyperfunction
in children. It was designed to: (1) review the clinical and
laboratory presentation of children with adrenal tumors
or bilateral adrenal hyperplasia; (2) determine methods
to aid in distinguishing adrenal from pituitary disease;
(3) determine whether adrenal carcinomas could be dif-
ferentiated from adrenal adenomas; (4) identify the in-
cidence of Nelson's syndrome in patients who have un-
dergone adrenalectomy; and (5) establish the indications
for and results of adrenalectomy.
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Materials, Methods, and Results
An examination of the records at the North Carolina
Memorial Hospital revealed that in the last 20 years we
have cared for 18 patients, ranging in age from 18 months
to 18 years, with cortical hyperadrenalism exclusive of
patients with congenital adrenal hyperplasia or hyper-
aldosteronism. Nine of these 18 children had bilateral
adrenal hyperplasia (5 males, 4 females), eight had adrenal
tumors (2 males, 6 females), and one girl had micronod-
ular hyperplasia. The age distribution of these patients
at the time of presentation is demonstrated in Figure 1.
The patient with micronodular adrenal hyperplasia was
12 years old at the time of presentation.
Table summarizes the clinical findings in our 17
patients with adrenal tumors or hyperplasia. One patient
with micronodular hyperplasia is not included, although
her clinical presentation was indistinguishable from that
of patients with bilateral adrenal hyperplasia. In all pa-
tients with bilateral adrenal hyperplasia, linear growth
deceleration antedated diagnosis by intervals up to 6 years.
Conversely, linear growth acceleration was a prominent
finding in five ofsix growing children with adrenal tumors.
Normal growth was present in a 4-year-old girl with com-
bined cortisol and androgen excess.
Patients with bilateral adrenal hyperplasia had classical
signs and symptoms of Cushing's syndrome in contrast
to those with adrenal tumors who presented primarily
with inappropriate virilization and/or feminization. This
distinction was not, however, complete. Although none
of the patients with bilateral adrenal hyperplasia had in-
appropriate clitoral or penile enlargement, many showed
mild hirsutism. Likewise, a few ofthe patients with adrenal
tumors presented with mild to moderate cushingoid fea-
tures.
Chemical and hematologic evaluation of our patients
is summarized in Table 2. Data on one patient with mi-
cronodular hyperplasia and one patient with bilateral ad-
renal hyperplasia are not included. Data on the former
patient (L.P.) will be presented (vida infra). The second
patient (T.N.) may have a unique form ofbilateral adrenal
hyperplasia and will be reported elsewhere. Glucose in-
tolerance was not observed in the patients included in
Table 1, although T.N. developed both severe diabetes
and metabolic alkalosis with associated renal stones.
The studies chosen to determine the presence ofcortisol
excess reflect the "state of the art" methodology at the
time the patient was studied and included A.M., P.M.,
and midnight blood cortisol levels, 24-hour urine collec-
tions for 17-hydroxycorticosteroids or free cortisol and
the dexamethasone suppression test. Although all eight
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FIG. 1. Age distribution of patients with adrenal tumors and bilateral
adrenal hyperplasia. Eight patients with Cushing's disease and one with
ectopic ACTH of an undefined source are included in the latter group.
normality in one or more ofthese tests, the number stud-
ied with each test is inadequate to compare their respective
reliabilities. Two patients with bilateral adrenal hyper-
plasia did not suppress with low dose dexamethasone,
although the dose was appropriate for their size.
Evaluation of androgen excess primarily included uri-
nary 1 7-ketosteroids and plasma testosterone levels. Four
patients with bilateral adrenal hyperplasia had normal
17-ketosteroids and four had borderline levels. All eight
patients with adrenal turnors had elevated urinary 17-
ketosteroids. The elevation was markedly higher than
those observed in our patients with bilateral adrenal hy-
perplasia.
Several additional tests were used to distinguish adrenal
tumors from bilateral adrenal hyperplasia. Six of eight
patients with adrenal tumors failed to show normal
suppression ofurinary 1 7-ketosteroids in response to high
dose dexamethasone. Blood ACTH levels were elevated
in two of three children with bilateral adrenal hyperplasia.
A third patient had two normal determinations (55 and
105 pg/ml; normal < 130 pg/ml). Despite these normal
values, this patient had a pituitary adenoma. Adreno-
corticotrophic hormone stimulation tests were performed
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TABLE 1. Presenting Signs and Symptoms of Corticol Hyperadrenalism in Eight Children with Adrenal Tumors
and Nine Children with Bilateral Adrenal Hyperplasia
Adrenal Tumors Bilateral Adrenal Hyperplasia
(8 Patients: 2 males, 6 females) (9 Patients: 5 males, 4 females)
Not Not
Not Known Not Not Known Not
Present Present if Present Applicable Present Present if Present Applicable
Sign/Symptom No. No. No. No. No. No. No. No.
Features of cortisol excess
Linear growth deceleration 0 5 1 2 9 0 0 0
Hypertension 1 4 3 0 5 4 0 0
Truncal obesity 2 1 5 0 7 1 1 0
Moon facies 3 1 4 0 9 0 0 0
Plethora 1 1 6 0 7 1 1 0
Buffalo hump 0 2 6 0 7 2 0 0
Easy bruisability 0 3 5 0 5 2 2 0
Striae 0 3 5 0 7 1 1 0
Muscle weakness 0 3 5 0 4 1 4 0
Hyperpigmentation 0 0 8 0 5 0 4 0
Features of cortisol or
androgen excess
Emotional changes 4 1 3 0 2 4 3 0
Increased body hair 6 2 0 0 5 0 4 0
Acne 7 0 1 0 9 0 0 0
Menstrual changes 2 0 0 6 0 0 2 7
Features of androgen excess
Linear growth acceleration 5 0 1 2 0 9 0 0
Inappropriately deep voice 3 1 4 0 0 0 9 0
Increased muscle mass 3 1 4 0 0 1 8 0
Inappropriate facial hair 4 1 3 0 3 1 5 0
Inappropriate sexual hair 6 0 0 2 2 5 2 0
Inappropriate clitoral or
penile enlargement 4 1 3 0 0 6 3 0
Inappropriate feminization 1 5 0 2 0 9 0 0
on one patient with bilateral adrenal hyperplasia and three
patients with adrenal tumors. As predicted, the patient
with bilateral adrenal hyperplasia had an exaggerated re-
sponse with significant elevation of urinary 17-hydroxy-
corticosteroids and the three patients with adrenal tumors
had no significant change in 17-hydroxycorticosteroids
excretion. There were no findings that differentiated before
surgery between adrenal adenomas and carcinomas.
The radiologic findings in eight patients with adrenal
tumors reflect the evolution of radiologic diagnosis during
the two decades of this study. Plain films of the abdomen
demonstrated a 19-cm carcinoma in one patient and a
4.5-cm adenoma in an 18-month-old boy. Intravenous
pyelography was the most common roentgenogram ex-
amination and revealed an adrenal mass in all seven pa-
tients undergoing this examination. In two patients an
arteriogram was performed, revealing a suprarenal mass
without major vessel abnormality in one and a "tremen-
dous partially cystic mass" in another. A hepatic arte-
riogram identified a "solitary" liver metastasis in the latter
patient 9 months following adrenalectomy. In the one
patient studied since the availability of ultrasound and
computerized tomography, a 2-cm adrenal tumor (8 gm)
was demonstrated by both techniques.6 Computerized
tomography demonstrated "nodules" in the patient with
micronodular hyperplasia. However, this proved to be a
false-positive interpretation since, although enlarged, the
adrenals had no gross nodularity. Iodocholesterol scans
and venograms were not used. Radiologic findings in
patients with Cushing's disease demonstrated osteopenia
in six of eight patients. Skull x-rays were normal in five
of seven patients studied. One patient had sellar demin-
eralization and one (P.S.) had sellar enlargement. Com-
puterized topographic (CT) scans were positive in both
patients studied (C.S. and P.S.; Fig. 3).
Seven patients with bilateral adrenal hyperplasia and
one with bilateral micronodular hyperplasia underwent
total adrenalectomy. Two patients with adrenal hyper-
plasia underwent transsphenoidal resection of a pituitary
tumor. Unilateral adrenalectomy was performed in the
eight patients with neoplasms. All adrenal tumors were
approached anteriorly through a subcostal incision with
a wide excision ofthe adrenal, surrounding fat, and areolar
tissue. There was no extension to lymph nodes, kidney,
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TABLE 2. Chemical and Hematological Findings in Eight Children with Adrenal Tumors and Eight Children with Bilateral Adrenal Hyperplasia
Adrenal Tumors (8) Bilateral Adrenal Hyperplasia (8)
Not Not
Positive Negative Determined Positive Negative Determined
or or Borderline or Not or or Borderline or Not
Abnormal Normal Result Applicable Abnormal Normal Result Applicable
Hematologic abnormalities
Erythrocytosis 2 4 1 1 1 4 2 1
Eosinopenia 2 2 0 4 3 4 0 1
Electrolyte or glucose
abnormalities
Hypokalemia 0 7 0 1 0 8 0 0
Hypochloremia 0 7 0 1 0 7 0 1
Elevated fasting blood sugar 0 6 0 2 0 6 0 2
Glucosuria 0 6 0 2 0 7 0 1
Bone age determination
Accelerated 3 1* 0 4
Delayed 1 7 0 0
Evaluation of cortison excess
Blood cortisol level
A.M. 0 1 0 7 0 4 0 4
P.M. 2 0 0 6 3 0 1 4
Midnight 0 0 0 8 1 0 0 7
Lack of diurnal variation 1 0 0 7 2 2 0 4
24-hour urinary free cortisol 1 0 0 7 1 0 0 7
24-hour urinary 17-
hydroxycorticosteroids 3 5 0 0 7 0 1 0
Dexamethasone suppression test
Low dose 3 0 0 5 6 2 0 0
High dose 3 0 0 5 0 6 0 2
Evaluation of androgen or
estrogen excess
24-hour urinary 17-ketosteroids 8 0 0 0 0 4 4 0
Blood testosterone 6 0 0 2 4 1 0 3
Dihydroepiandosterone-sulfate
(DHEAS) 0 1 0 7 0 0 0 8
24-hour urinary pregnanetriol I 1 0 6 0 0 0 8
Estradiol 1 0 0 7 0 0 0 8
Miscellaneous differentiating tests
ACTH Level 0 0 0 8 2 1 0 5
ACTH stimulation test 3t 1 0 4 1§ 0 0 7
24-hour urinary 1 7-ketosteroid
response to high dose
dexamethasone suppression 6t 0 0 2 2 4 1 1
* Bone age was not accelerated in the child with combined cortisol
and androgen excess.
t Urinary 17 hydroxycorticosteroids did not increase significantly in
response to ACTH in these three patients; one would expect this result
in patients with an autonomous adrenal tumor.
liver, or vena cava in any patient. Bilateral adrenalectomy
was accomplished via bilateral posterior lumbar incisions
in seven patients and via a midline incision in one.
With the exception ofthree carcinomas (weighing 1600,
440, and 130 gms), tumors were of modest size, for ex-
ample, 8, 12, 25, 52, and 60 gms. Histopathologic findings
in six of the tumors were similar. Large pleomorphic and
multinucleated cells were frequently found. Many of these
cells had bizarre nuclei with eosinophilic cytoplasmic in-
tranuclear invaginations. All of the neoplasms showed
sinusoidal vascular invasion and two (one adenoma and
t Urinary 1 7-ketosteroids did not decrease in response to high dose
dexamethasone.
§ Hyperresponse as one would expect with bilateral adrenal hyperplasia.
Normative data based on References 1, 2, 3, 4, and 5.
one carcinoma) showed tumor thrombi in a vein. The
eighth and largest tumor ( 1600 gms) differed significantly
from the others only in that frequent and atypical mitotic
figures were found and distinctly spindled tumor cells
were present. This lesion subsequently recurred and in-
vaded the liver. None of the other lesions, even those
classified as carcinoma on the basis of weight, had more
than a rare mitotic figure.
In the absence of identifiable invasive or metastatic
disease at the time of diagnosis, tumor mass appears to
be the best criterion of malignancy and, in accord with
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FIG. 2. Aberrations in growth
of a boy with a virilizing/
120 feminizing adrenal adenoma
(Case Report 1) and a boy
100 with Cushing's disease (Case
Report 2). Note return of
so height velocity to normal
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published criteria, encapsulated lesions weighing over 75
gms were classified as carcinoma on the basis of weight
alone.7'8 In our study, intravenous thrombi, multiple nu-
cleated giant cells, and large bizarre nuclei were not in-
dications of malignancy in the absence of abnormal mi-
PATIENT AGE
































FIG. 3. Survivorship in patients with Cushing's disease is portrayed.
Note that four ofsix patients developed Nelson's syndrome. X-ray therapy
(4500-5000 R) using a cobalt source was utilized in the management
of Nelson's syndrome and the one patient who had recurrence of Cush-
ing's disease after transsphenoidal surgery.
toses. The one clearly malignant lesion in our series was
the only lesion that had abnormal and excessive mitoses
and contained large numbers of bizarre spindled tumor
cells. The pituitary lesions removed in two patients un-
dergoing transsphenoidal surgery had histologic features
of "basophilic adenoma."
The results of treatment of eight patients with adrenal
tumors are depicted in Figure 4. Of the three patients
with carcinoma, one expired of advanced disease 20
months after adrenalectomy and 8 months after partial
hepatectomy for liver metastasis. The administration of
O,p'DDD was poorly tolerated in this patient. Two pa-
tients are well with normal growth and development 11
and 20 years following adrenalectomy. The relatively good
survivorship in these two patients with adrenal carcinoma
may be related to the small size of their tumors (130 and
440 gms). With the exception of one patient who died 6
years after surgery from a glioblastoma multiforme, all
patients with adrenal adenomas are well at 1, 9, 9, 10,
and 11 years following operation. The association between
brain tumors and adrenal tumors has been observed by
others.9
The course of eight patients with Cushing's disease is
presented in Figure 3. Of the seven patients who have
reached their final adult stature, all but one have signif-
icant short stature (< third percentile). Two patients are
otherwise well on replacement therapy at 15 and 16 years
after bilateral adrenalectomy and one patient is well 1 l/2
years after transsphenoidal surgery. Three patients de-
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veloped Nelson's syndrome (cutaneous hyperpigmenta-
tion associated with a pituitary tumor) at 2, 6, and 12
years postadrenalectomy. The first patient (L.W.) was
treated by 4800 R of external irradiation but required
total hypophysectomy 5 years later. S.H. underwent ir-
radiation therapy and remains well 9 years later. S.M.
required total hypophysectomy followed by irradiation
(4500 R) 12 years after adrenalectomy. His tumor had
extended into the sphenoid sinus. A.S. was treated by
4800 R of external irradiation and remains well 6 years
later. P.S., treated initially by transsphenoidal surgery,
developed decreased visual acuity and a blind spot im-
mediately after operation. One year later she received
irradiation (4800 R) for recurrent Cushing's disease. Al-
though her Cushing's disease has resolved, she has growth































H PARTIAL HEPATEC-TOMY FOR METASTASIS
FIG. 4. Survivorship in eight patients with adrenal tumors revealed only
one death from adrenal carcinoma. This patient was also treated with
mitotane (O,p'DDD) which was poorly tolerated.
Case Reports
Case 1. J.C. presented at age 4.6 years with a 1-year history of breast
enlargement, a 6-month history of acne and body odor, and a 3-month
history of pubic hair development and penile enlargement. Physical
examination revealed a virilized young boy with a deep voice. His height
and weight were greater than the 97th percentile for age (Fig. 2). He
was normotensive. There was bilateral glandular breast tissue, measuring
2.5 cm in diameter on the left and 2.2 cm in diameter on the right.
There was sparse axillary hair and Tanner Stage 2 pubic hair. The
scrotum was rugated and the testes measured 2.3 X 1.1 cm on the right
and 2.1 X 1.1 cm on the left. Stretched penile length was 6 X 2.3 cm.
There were no cushingoid features and the remainder of the examination
was normal. Review ofgrowth records revealed accelerated linear growth
(Fig. 2). Bone age was 8 years and skull x-ray demonstrated a normal
sella. Abdominal x-ray revealed no calcifications.
True precocious puberty was initially considered the most likely di-
agnosis since the testes were at the upper limits of normal prepubertal
size, suggesting they were under gonadotrophic stimulation. Further
evaluation, however, was not consistent with this impression. Electrolytes
and the hemogram were normal. Baseline 24-hour urinary 17-hy-
droxycorticosteroids were 2.6 mg/m2 (normal). Follicle-stimulating hor-
mone (FSH) was 2.0 mlu/ml (prepubertal). Twenty-four hour urinary
1 7-ketosteroid excretion was 7.7 mg (normal <2 mg). Plasma testosterone
was 145 ng/dl (normal: 4.1-8.1 ng/dl). Twenty-four hour urinary preg-
nanetriol was elevated at 7 mg (normal: 1 mg). Serum estrogen was
40.2 ng/dl (normal: 0). Seventeen-ketosteroid excretion did not decrease
in response to high dose dexamethasone suppression. Adrenocortico-
trophic hormone stimulation did not result in a significant rise in either
urinary 1 7-ketosteroids or 1 7-hydroxycorticosteroids. An intravenous
pyelogram revealed a 3 X 3 cm left suprarenal mass. Left adrenalectomy
with excision of periadrenal fat was performed using a left subcostal
approach. Pathological examination demonstrated a 52-gm encapsulated
tumor with a small portion of normal adrenal at one margin. Micro-
scopical evaluation showed sheets and trabeculae of cells with large,
clear, finely vesiculated nuclei, many with one or more nucleoli. In
some areas, tumor cells involved the inner layer of fibrous capsule but
did not extend to outer layers. In other areas, tumor cells appeared to
invade the walls of small veins and were also encountered in the lumen
of vascular channels.
The immediate postoperative course was uncomplicated except for
transient signs of hypocortisolism. This patient was most recently eval-
uated at age 11.9 years. He is on no medication except insulin for
diabetes mellitus. Urinary 17-ketosteroids, androstenedione, testosterone,
and estradiol were normal. Growth is at a normal velocity along the
75th percentile.
Comment
The clinical presentation and endocrinological findings
in this patient are representative ofa virilizing/feminizing
tumor of the adrenal cortex. The microscopic findings
were characteristic and, although tumor cells were present
in veins, such a finding was also noted in other patients
with adrenal adenomas. The tumor in this patient was
regarded as an adenoma on the basis of weight.
Case 2. C.P. was referred at 14.8 years of age for evaluation of short
stature. Growth data demonstrated deceleration of linear growth velocity
beginning approximately 4 years prior and essentially no growth for 3'/2
years (Fig. 4). Height was well below the third percentile and weight
was at the tenth percentile for age. He was normotensive. Findings
included a suggestion of a moon facies, acne, a small "buffalo hump,"
moderate nontruncal obesity, a low hairline, striae, fine lanugo hair on
the extremities, and thin skin over the knuckles. Hyperpigmentation
was not present. There was Tanner Stage 3 pubic hair development.
The electrolytes and hemogram were normal except for eosinopenia.
The bone age was delayed by 2 years. Morning cortisol level was normal
at 17 ug/dI, with an evening cortisol elevated at 26 ug/dl. Twenty-four
urinary 17-hydroxycorticosteroids were elevated at 7.9 mg (6 mg/m2/
d; normal: 0.9-4.9 ng/m2/dl). Cortisol levels suppressed only with high
dose dexamethasone. Urinary 17-ketosteroids and plasma testosterone
levels were normal. Radiologic examination revealed osteoporosis with
compression fractures of T4-8. The skull x-ray was normal as was a
nephrotomogram. Bilateral adrenalectomy was carried out with the right
adrenal weighing 4.5 gms and the left 4 gms. Microscopic evaluation
was consistent with bilateral adrenal hyperplasia. Although stunted (final
adult height 5 feet), C.P. had done well on replacement therapy up
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through the time of his last visit at age 21. However, he has subsequently
developed headaches associated with vomiting and he is currently un-
dergoing evaluation for Nelson's syndrome.
Comment
This patient illustrates a case of childhood Cushing's
disease with associated growth failure and ultimate stunt-
ing. He demonstrates the need to monitor these patients
indefinitely for the development of Nelson's syndrome.
Case 3. L.P., a 12-year-old female, was seen because of a 3-4 year
history of cushingoid features including a decrease from the 25th to the
third percentile in height. The patient had previously undergone repair
of a patent ductus arteriosus and ventriculoseptal defect at age 4, place-
ment of a ventriculoperitoneal shunt for obstructive hydrocephalus at
age 6, and evacuation of a left chronic subdural hematoma at age 11.
A maternal aunt had Cushing's syndrome secondary to an adrenal ad-
enoma. Another maternal aunt had a parathyroid adenoma.
Physical examination revealed a pleasant cushingoid white girl. Height
was less than the third percentile and weight was the 25th percentile
for age. Blood pressure was 132/86. There was mild acne and striae but
no bruising or hyperpigmentation. Breasts were Tanner Stage 2 and
pubic development was Tanner Stage 4. The remainder of the exami-
nation was noncontributory.
Laboratory studies indicated a normal hemogram, urinalysis, and an
SMA-6. Glucose was 83 mg/dl. There was loss ofdiurnal cortisol variation
(8 A.M.-36.3 ug/dl; 4 P.M.-29.9 ug/dl). On venous catheterization
the cortisol level from the left adrenal vein was 253 ug/dl, from the
right adrenal vein 165-218 ug/dl, and from a peripheral vein 23.5 ug/
dl. There was no suppression of urinary free cortisol, 17-OHCS or 17-
KS, with low (20 ug/kg/day) or high (80 ug/kg/day) dose dexamethasone.
The ACTH level was 30 pg/ml (normal: .130 pg/ml). A CT scan of
the abdomen revealed two 1-cm nodules in the right adrenal and a
1-cm nodule in the left adrenal.
With the clinical impression of hypercortisolism secondary to bilateral
nodular adrenal hyperplasia, the patient underwent bilateral adrenal-
ectomy through flank incisions. Although there was no gross nodularity,
both glands had micronodular changes. A grossly normal segment of
the right gland was diced into 25 2 x 1 mm pieces that were implanted
in the left volar forearm musculature. Pathological examination disclosed
bilateral multiple nonencapsulated cortical nodules containing lipid-
laden cells in compact arrangement. Many cells contained lipofuchsin.
There was significant nuclear enlargement in a few cells within each
nodule. There were no architectural changes to suggest malignancy.
The patient's postoperative course was unremarkable. She is currently
maintained on cortisone acetate and fludrocortisone. During the 15
months since adrenalectomy, she has had a gradual change in overall
body habitus to that of a normally proportioned adolescent girl. She is
normotensive. Menses have started, linear growth has resumed, and she
has a height prediction of 4 ft, 11 in-5 ft.
Comment
This patient's endocrinological and pathological find-
ings are characteristic of micronodular adrenal hyper-
plasia. Micronodular adrenal hyperplasia appears to be
a variant of nodular adrenal hyperplasia, which is a het-
erogeneous group of disorders varying from one or more
nodules to diffuse nodular hyperplasia.'0-'4 The patho-
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genesis of these disorders is unknown. In a few patients
there appears to be pituitary dependence, although most
demonstrate impaired suppression to dexamethasone. 11-13
Adrenocorticotrophic hormone levels are usually sup-
pressed but may be elevated." Although adrenalectomy
has been the most common therapeutic approach, pi-
tuitary tumors have been observed with the development
of Nelson's syndrome after surgery. Remission has been
reported following pituitary surgery or radiation therapy. "
Discussion
Adrenocortical hyperfunction due to adrenal tumors
and bilateral adrenal hyperplasia of pituitary or hypo-
thalamic origin are rare conditions at any age. When
these conditions present in children and adolescents, there
are certain unique features that must be considered in
terms of clinical presentation, evaluation, treatment, and
outcome.
The clinical features and laboratory findings demon-
strated by our patients are similar to those described by
others.'523 Although female preponderance has been
noted among adults with Cushing's disease,'0 no sexual
predilection was observed in our children with Cushing's
disease and none has been noted in the literature.'9'2',24-26
In contrast, there is a female preponderance among chil-
dren with adrenal tumors 20,23,26,27 This is illustrated by
our series in which six of eight children with adrenal
tumors were female. The literature indicates that children
under age eight with Cushing's syndrome are more likely
to have an adrenal tumor while those over this age are
more likely to have Cushing's disease.2' This generaliza-
tion is consistent with our data in which the youngest of
eight patients with Cushing's disease was 9.6 years at the
time of presentation. Although the age of the child pre-
senting with cortisol excess is useful in differentiation,
about 15-25% of children with Cushing's disease present
before 8 years of age28 andi Cushing's disease has even
been demonstrated in infancy.16
Our patients presented with signs and symptoms that
were typical and appropriate for their underlying disease.
Nine patients with bilateral adrenal hyperplasia and one
patient with micronodular hyperplasia had findings
suggestive of significant cortisol excess and mild androgen
excess. Six of our eight patients with adrenal tumors pre-
sented with virilization with or without mild signs of
cortisol excess; one presented with mixed cortisol and
androgen excess; and the last presented with virilization
and feminization. An abnormality in linear growth was
the single most constant sign of hyperadrenalism. Patients
with androgen excess alone demonstrated linear growth
acceleration, whereas patients with glucocorticoid excess
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uniformly suffered growth arrest. Although androgen ex-
cess causes increased skeletal maturation regardless of
glucocorticoid status, androgens cannot overcome the in-
hibitory effect of glucocorticoid excess on linear growth.
Indeed, this inhibitory effect of glucocorticoid secretion
on linear growth is so invariable that the finding ofnormal
growth in an obese child excludes the possibility of un-
derlying hyperadrenalism and eliminates the need for fur-
ther evaluation.
Laboratory evaluation of our patients was consistent
with findings reported by other workers.'6 When evalu-
ating children for cortisol or androgen excess, age, weight,
surface area, and pubertal status are needed for reliable
testing and interpretation. For example, the dosage for
dexamethasone suppression testing must be adjusted to
each child's weight. In addition, patients with virilization
should be evaluated for other virilizing syndromes. These
include congenital adrenal hyperplasia, exogeneous an-
drogen administration, maternal androgen excess (in the
case of a newborn), true precocious puberty, premature
adrenarche, male pseudohermaphrodism, chromosomal
anomalies (XO/XY mosaicism), testicular or HCG pro-
ducing tumors, ovarian tumors, and Stein-Leventhal syn-
drome. Patients who present with hypercortisolism should
be questioned regarding exogeneous steroid use, including
the application oftopical steroid preparations. In practice,
the major differential in males is central precocious pu-
berty that is suggested by symmetrically enlarged testes
secondary to gonadotrophin stimulation. In both sexes,
congenital adrenal hyperplasia must be seriously consid-
ered and, in girls, Stein-Leventhal syndrome commonly
presents with mild virilization. Severe forms ofcongenital
adrenal hyperplasia present in infancy with ambiguous
genitalia in genetic females or as an addisonian crisis in
either sex. Mild forms are more difficult to diagnose,
although the 1 7-hydroxyprogesterone response to ACTH
may be useful. After considering these conditions, ap-
propriate laboratory evaluation for an adrenal tumor and
Cushing's disease can proceed. As indicated in our sub-
jects, no single test was uniformly diagnostic ofCushing's
disease or adrenal tumor. However, clinical presentation
in combination with several appropriate laboratory and
radiologic studies should lead to the appropriate diagnosis.
The histologic features that differentiate adrenal ade-
noma from carcinoma are ambiguous. Nuclear size, an-
aplasia, and number of mitoses are not considered to be
as reliable as capsular or vascular invasion.7'8 However,
in this group of patients, sinusoidal invasion could be
demonstrated in all tumors. Although mitoses were more
prominent in the patients with carcinoma, their absence
did not exclude this diagnosis. Although the most reliable
criterion is the presence of metastatic disease, the literature
supports the finding that a neoplasm greater than 75 gms
is more likely malignant.7 8 Hayles was first to emphasize
the likelihood of metastasis being best correlated with the
relation of tumor weight to body weight, for example,
>0.7 gm/100 gm of body weight. In his review of 32
children,'9 the incidence of metastasis was 13% in patients
with tumors below this weight compared with 50% in-
cidence in tumors above this weight. Utilizing Hayles
criteria, the tumors of five patients in this series would
be considered malignant, namely, D.P., M.W., D.L.,
M.T., and H.W. All tumors regardless of size should ini-
tially be regarded as potentially malignant. Wide surgical
excision is advised, although the value is not well estab-
lished since recurrence is rarely local except in very large
neoplasms. Recurrence is most likely to be manifest by
metastatic disease in liver, lung, lymph nodes, and oc-
casionally brain.'7'30 Tumor size appears to be a greater
factor in influencing survivorship than the extent of sur-
gical treatment.
The relatively excellent survivorship in these patients
with adrenocortical neoplasms is unusual. Of eight pa-
tients, only one died of recurrent disease and this was a
17-year-old girl whose original tumor was 19 cm in di-
ameter, weighed 1600 gms, and had numerous mitotic
figures. Ofthe remaining seven patients, six are alive and
well from 1 to 20 years after adrenalectomy (Fig. 2). One
patient expired 6 years after adrenalectomy from a brain
tumor (glioblastoma multiforme) without evidence of re-
current adrenal carcinoma. The neoplasms in the six sur-
viving patients were all ofmodest size with weights varying
from 8 to 440 gms.
Computerized tomography is the single most effective
radiologic means of establishing the diagnosis of primary
adrenal disease with an estimated accuracy of 90%.27,31,32
Computerized tomography is also valuable in screening
for lung metastasis and recurrence in the adrenal bed.
Adrenal disease may also be evaluated via adrenal venous
sampling (100% accuracy), venography (75%), and ar-
teriography (58%).3' These latter methods are associated
with increased risk but may be required in selected cir-
cumstances. Ultrasound may be helpful and is useful for
evidence ofinvasion ofthe inferior vena cava in malignant
tumors. Characteristic findings in adrenocortical carci-
noma are a tumor greater than 9 cm in diameter with
varying degrees of necrosis.32
Current Management
Various modes of treatment have been used for Cush-
ing's disease in children. These include bilateral adre-
nalectomy, pituitary irradiation, chemotherapy, and more
recently transsphenoidal surgery. The greatest experience
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in the management of children has been with bilateral
adrenalectomy. While this has been effective, the dis-
advantages are well recognized. These include an operative
mortality of4-10% in adults,'0 occasional recurrence due
to ectopic- adrenal tissue,'0 the need for lifetime corti-
costeroid and mineralocorticoid replacement, potential
for addisonian crisis and the development of Nelson's
syndrome. Nelson's syndrome is comprised of hyperpig-
mentation and a pituitary tumor following adrenalec-
tomy.33'34 The hyperpigmentation is presumably second-
ary to a postoperative rise in ACTH secretion. Devel-
opment of Nelson's syndrome is associated with
enlargement of a corticotroph adenoma that can become
invasive, extend beyond the pituitary fossa, and lead to
cranial nerve impairment.35 The incidence of this syn-
drome in children in two ofthe larger series is over 50%2428
which is higher than that reported for adults (10-20%).10,36
After adrenalectomy, children usually have normal growth
and sexual development unless growth has been severely
compromised by long-standing disease prior to surgery.
In addition to hyperpigmentation, patients should be
monitored for the development of visual field defects and/
or an enlarging sella turcica. If Nelson's syndrome de-
velops and is treated with irradiation or extensive pituitary
surgery, panhypopituitarism with associated growth fail-
ure, hypogonadism, and diabetes insipidus may develop.28
Total adrenalectomy at present would appear to have
its primary role in: (1) patients in whom there is an un-
defined ectopic source of ACTH; (2) patients in whom
the disease originates in the adrenals, for example, most
individuals with micronodular adrenal hyperplasia; and
(3) patients with recurrent Cushing's disease after prior
pituitary irradiation. Two patients in the current series
fell in this category, one with micronodular adrenocortical
hyperplasia and one in whom the highest ACTH level
was in the region of the hepatic veins and in whom the
ACTH level fell after adrenalectomy. Recent studies have
demonstrated that the adrenal medulla can produce
ACTH.37'38 This patient may have had her disease on the
basis of an adrenal source of ACTH. Adrenalectomy is
appropriate in recurrent disease following prior pituitary
irradiation since these patients arre less likely to develop
Nelson's syndrome and the technical problems associated
with a transsphenoidal approach may be formidable.
Our data clearly show that while adrenalectomy is in-
dicated for adrenal neoplasms, transsphenoidal hypo-
physectomy is the current treatment of choice for Cush-
ing's disease. The high incidence of Nelson's syndrome
following bilateral adrenalectomy in this condition makes
it clear that total adrenalectomy should be abandoned
until such time as further research leads to medical means
of preventing this development. Successful excision of
the pituitary adenoma should leave pituitary hormone
production intact and permit normal growth and devel-
opment without the need for replacement therapy. There
are, however, limitations of pituitary surgery. Recurrent
disease appears to be more of a problem than in adults
undergoing a similar operation. In a recent report, re-
currence was reported in four of 13 patients below the
age of 20 within a 2-year follow-up.39 A high incidence
of recurrence has also been noted by others.40 One ofthe
patients in this series treated by transsphenoidal surgery
had recurrence at 2 years. The reason for this higher
recurrence rate is unknown. This could be due to a more
aggressive nature of childhood tumors, multiple adeno-
mas, or to a higher proportion of primary hypothalamic
lesions in children. In addition, there is an appropriate
effort to preserve a functioning pituitary gland and to
avoid total hypophysectomy in this age group. This may
result in a more conservative surgical approach. The mi-
nute size (mean 5 mm) ofsome pituitary microadenomas
may result in difficulty in their identification at the time
of transsphenoidal surgery. Bilateral petrosal sinus sam-
pling for ACTH in patients with occult adenomas-not
localized by computerized tomography-may permit
hemiresection of the pituitary if the lesion is too small
to be recognized at surgery.4'
Pituitary irradiation has been advocated primarily by
Jennings25 as the preferred treatment in children with a
report of 15 patients treated over a 20-year period ter-
minating in 1977. Failure occurred in three who subse-
quently required adrenalectomy. Sexual development was
reported to be normal in all, growth was stated to be
"normal" for all adolescent children, and neither Nelson's
syndrome nor recurrent disease has developed. In eight
patients treated before age 16, stature was short but con-
sidered socially acceptable (5 ft, 1.6 in-5ft, 5 in). A major
limitation of irradiation is the time lag between the ini-
tiation of therapy and resolution of hypercortisolism (6-
18 months). It is ofextreme importance during childhood
to terminate the disease immediately because of the ad-
verse effects ofeven mild cortisol excess on growth. Unlike
some forms of growth failure, "catch-up growth" does
not occur after correction of cortisol excess. As a con-
sequence, we favor a form of treatment that produces
more immediate results. However, in instances where
transsphenoidal hypophysectomy fails to lead to a defin-
itive cure, the treatment of choice at the present time is
probably conventional irradiation as advocated by Liddle
and the Vanderbilt group.25
Experience with drug therapy in children has been lim-
ited and in general unsatisfactory.'5 Drugs that inhibit
steroidogenesis (mitotane [O,plDDD], aminoglutethimide,
metyrapone, and trilostane) are not uniformly effective
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or practical for long-term management.'5 Drugs acting
on neurotransmitters believed to regulate corticotropin
releasing factor, for example, cyproheptadine and bro-
mocryptine, have been used in a small number ofchildren
to suppress ACTH secretion.'5 Major limitations to cy-
proheptadine therapy include severe appetite stimulation
with excessive weight gain and delayed therapeutic effect.42
In the future, measurement of corticotropin releasing
factor may help define the role of the hypothalamus in
the etiology of Cushing's disease. The intravenous ad-
ministration of corticotropin releasing factor with mea-
surements ofACTH secretion has been shown to facilitate
differentiation of ACTH dependent Cushing's disease
(hyperresponsiveness) from ectopic ACTH production (no
further increase) and hypercortisolism of adrenal origin
(ACTH remains suppressed).43
There is little or no controversy about the management
ofadrenal tumor producing Cushing's syndrome. Excision
of the adrenal tumor in association with periadrenal fat
and lymph nodes is well accepted as treatment of choice.
An anterior approach is usually advised becasuse it pro-
vides wide exposure in the case ofa malignant neoplasm.
The prognosis in adrenal tumors is related primarily to
tumor size. There is excellent survivorship in patients
whose tumor is below 75 gms in weight. Studies on ACTH
and other hormone receptor sites (PGE,, L.H., glucagon,
epinephrine, and TSH) in adrenal tumors demonstrate
a heterogeneity of responses."444 Additional data may
help differentiate benign from malignant tumors. Malig-
nancy may be difficult to define by histologic criteria and
metastatic disease is the ultimate criterion ofadrenal car-
cinoma which has a dismal prognosis. It is doubtful that
the benefits associated with resection ofdistant metastases,
for example, liver, warrant such an approach except as
a palliative measure. The poor results of excision of ad-
enocarinoma reported in earlier years are related to the
large size of the tumor at operation and inadequate re-
placement therapy. The sensitivity of ultrasound and CT
in evaluating patients with suspected adrenal neoplasms
should permit earlier diagnosis and improved results.
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DISCUSSION
DR. JOHN C. FLETCHER (Tampa, Florida): I would like to ask Dr.
Thomas about the role of transplantation where bilateral adrenalectomy
is indicated.
DR. COLIN G. THOMAS, JR. (Closing discussion): That is a good
question. I think Dr. Hardy and his group have had the greatest experience
in adrenal transplantation, with some degree of success.
We have had one patient in whom we have undertaken adrenal trans-
plantation, a patient with micronodular hyperplasia in whom we trans-
planted some of the adrenal to the forearm. That was about 3 years ago
and we do not have enough data yet to know whether the transplant
is functioning or not. Adrenal transplantation may have a role, but the
exact role is undetermined.
I do have one slide that I thought might be of interest to you. In a
rather extensive search of the early literature, we identified a patient
who appeared to have a virilizing tumor. This patient is gargantua and,
as recorded by the physician, Rabelais, 1534, had a rather unique birth
and early message:
The cotyledons of her matrix were all loosened, above through which
the child sprung up and leaped, and so entering into the vena cava,
did climb by the diaphragm even above her shoulders (where that
vein divides itself into two) and from thence taking his way toward
the left side, issued forth at her left ear. As soon as he was born, he
cried, not as other babes used to do, but with a high, sturdy, and big
voice shouted aloud: "DRINK! DRINK! DRINK!" as if inviting all
the world to drink with him. The noise hereof was so extremely great
that it was heard in both the countries at once.
I think this a very appropriate quote for this Society.
